1-Eicosadienoyl-2-docosahexaenoyl-sn-glycero-3-phosphoethanolamine

Metabolite details

Identifier

SGQIECCWAOPTNL-LEFPGAKQSA-N

InChI Key

SGQIECCWAOPTNL-LEFPGAKQSA-N

IUPAC name

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(11Z,14Z)-icosa-11,14-dienoyl]oxypropan-2-yl] (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoate

Preferred name

1-Eicosadienoyl-2-docosahexaenoyl-sn-glycero-3-phosphoethanolamine

INN name

—

Synonym

—

ChEBI

CHEBI:176739

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• Global analysis of plasma lipidomics reveals altered lipid signatures in patients with osteonecrosis of the femoral head
• Gut microbiota production of trimethyl-5-aminovaleric acid reduces fatty acid oxidation and accelerates cardiac hypertrophy
• Lipidomic Changes in the Liver of Beagle Dogs Associated with Toxocara canis Infection
• Absolute quantitative lipidomics reveals lipidome-wide alterations in aging brain (Mouse brain NEG UPLC-MS assay)
• Transcriptomic and lipidomic profiling of subcutaneous and visceral adipose tissues in 15 vertebrates
• LION-web validation lipidomics experiments (FA-incorporation, membrane fluidty)

Observed in differential profiles

• Control_vs_AONFH_Stage_III_IV
• Wild_Type_vs_TMAVA_Treatment
• Control_12h_vs_Toxocara canis_12h
• 4_weeks_vs_52_weeks
• G1_Sheep_ASA_SAT_vs_G2_Sheep_GOM_VAT
• BSA_Control_vs_AA